7 The authors used a combination of ex-vivo and in-vivo techniques to investigate whether mice expressing CS mutations in Kir6.1 and SUR2 develop lymphatic vessel dysfunction and subsequent lymphedema. Here, KCNJ8 is linked to lymphedema.